How safe is a standard-risk child with ALL?

Jeanette Falck Winther; K. Schmiegelow

doi:10.1016/s1470-2045(14)70294-3

How safe is a standard-risk child with ALL?

Jeanette Falck Winther, K. Schmiegelow

Institut for Klinisk Medicin

8 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Lancet Oncology
Vol/bind	15
Udgave nummer	8
Sider (fra-til)	782-783
Antal sider	2
ISSN	1470-2045
DOI	https://doi.org/10.1016/s1470-2045(14)70294-3
Status	Udgivet - jul. 2014

Adgang til dokumentet

10.1016/s1470-2045(14)70294-3

Citationsformater

@article{bcc8587420d44a8ba178241a2daebf63,

title = "How safe is a standard-risk child with ALL?",

keywords = "Antineoplastic Combined Chemotherapy Protocols, Female, Humans, Male, Neoplasms, Second Primary, Population Surveillance, Precursor Cell Lymphoblastic Leukemia-Lymphoma",

author = "Winther, {Jeanette Falck} and K. Schmiegelow",

year = "2014",

month = jul,

doi = "10.1016/s1470-2045(14)70294-3",

language = "English",

volume = "15",

pages = "782--783",

journal = "The Lancet Oncology",

issn = "1470-2045",